Enantioselective plasma protein binding of bimoclomol
Article first published online: 15 JUL 2002
Copyright © 2002 Wiley-Liss, Inc.
Volume 14, Issue 8, pages 638–642, 2002
How to Cite
Visy, J., Fitos, I., Mády, G., Ürge, L., Krajcsi, P. and Simonyi, M. (2002), Enantioselective plasma protein binding of bimoclomol. Chirality, 14: 638–642. doi: 10.1002/chir.10117
- Issue published online: 15 JUL 2002
- Article first published online: 15 JUL 2002
- Manuscript Accepted: 24 FEB 2002
- Manuscript Received: 14 AUG 2001
- diabetic complications;
- glycoprotein subfractions;
- chiral analysis
The binding of bimoclomol enantiomers to human plasma, its components, as well as to plasma from monkey, dog, rat, and mouse was investigated by ultrafiltration and equilibrium dialysis. The considerably stronger binding of the (−)-(S)-enantiomer found in human plasma is due to the alpha1-acid glycoprotein (AAG) component. The binding parameters for AAG (nRKR = 1.3 × 104 M−1 and nSKS = 1.0 × 105 M−1) revealed high enantioselectivity, while the binding to human serum albumin was found to be weak (nK = 5 × 103 M−1) and not stereoselective. (−)-(S)-Bimoclomol was extensively displaced in the presence of specific marker ligands for the “FIS” subfraction of human AAG. Comparative binding studies indicated considerable differences between plasma of the five species investigated. Chirality 14:638–642, 2002. © 2002 Wiley-Liss, Inc.